Home › Mesothelioma › California
Mesothelioma clinical trials in California
12 studies for Mesothelioma are looking for participants at sites in California.
Cities in California
- Los Angeles6 studies
- San Diego4 studies
- Santa Monica3 studies
- Santa Rosa3 studies
- Mountain View3 studies
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- City of Hope Cancer Center-Duarte, Duarte
- Providence Medical Foundation, Santa Rosa
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07277413Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- University of California San Diego, La Jolla
- Stanford University, Palo Alto
- UCLA Medical Center, Santa Monica
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04981119TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
- USC Norris Comprehensive Cancer Center, Los Angeles
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04969315Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Stanford University, Palo Alto
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05732831SW-682 in Advanced Solid Tumors
- USC Norris Comprehensive Cancer Center and Hospital, Los Angeles
- UC San Diego Moores Cancer Center, Sacramento
- UCLA Hematology-Oncology - Santa Monica, Santa Monica
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06251310Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- University of California Los Angeles Medical Center, Los Angeles
- University of California, San Diego; Moores Cancer Center, San Diego
- USOR Sansum Clinic, Santa Barbara
- and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT05579366A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- UCSD Moores Cancer Center, La Jolla
- UCLA Medical Center, Los Angeles
- Stanford University, Stanford
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06051695A Study of VET3-TGI in Patients With Solid Tumors
- USC/Norris Comprehensive Cancer Center, Los Angeles
- UC Irvine Health, Orange
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 7, 2026 · NCT06444815Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 2, 2026 · NCT04665206VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Providence Medical Foundation (site 209), Santa Rosa
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Dec 11, 2025 · NCT03556228A Study of NX-1607 in Adults With Advanced Malignancies
- University of Southern California, Los Angeles
- University of California, San Francisco, San Francisco
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT05107674A Beta-only IL-2 ImmunoTherapY Study
- Sharp Memorial Hospital, San Diego
- Providence Saint John's Health Center, Santa Monica
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 9, 2025 · NCT05086692From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.